We
hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 13, 2019, relating to the consolidated
financial statements of ContraVir Pharmaceuticals, Inc., which is incorporated by reference in that Prospectus. Our report on the consolidated financial statements contains an explanatory
paragraph regarding the Company's ability to continue as a going concern.

We
also consent to the reference to us under the caption "Experts" in the Prospectus.